What Is LDN?
Naltrexone is an opiate receptor antagonist, which means it blocks the opioid receptor. It is a drug that was approved by the FDA in 1984 for treatment of opioid and alcohol addition in doses of 50-200mg. Lower doses ranging from 0.5mg to 9mg daily have the unique ability to modulate the immune system , and shown tremendous promise in providing relief to those suffering from chronic pain, auto-immune diseases, mental health challenges, and inflammation.
We educate your patients:
Through monthly LDN classes providing:
An overview of LDN
A comprehensive binder of supportive information
Shared testimonials of success
Lengthy question and answer opportunities.
Continued follow up
We provide for our prescribers:
One-on-one meetings between our educators and providers
Customized binders with current published LDN research
Timely and current approaches to individualized therapies
A team approach between patient, provider and pharmacist
Phone and/or email responses to questions and concerns.
The Medicine Center Maintains an expertise in all current LDN research, utilizing that knowledge to make recommendations to vary doses, titration approaches and dosing times.
This knowledge helps those taking LDN find their individualized dose, leading to greater success.